Form 4 Filing for BioStem Technologies, Inc.

This filing details a Form 4 filing for BioStem Technologies, Inc. concerning transactions by reporting owner WARRINGTON KENNETH HOWARD JR. On August 27, 2026, Mr. Howard acquired 5094 shares of Common Stock via a non-derivative transaction (code "A", price $0.00), increasing his post-transaction holdings to 32234 shares. Concurrently, he disposed of 5094 Restricted Stock Units (code "D", price $0.00), resulting in zero post-transaction holdings of RSUs. The filing also includes an exhibit detailing a Power of Attorney granted by Mr. Howard to Katherine Gorrell and others, authorizing them to make SEC filings on his behalf, manage his EDGAR account, and execute necessary forms related to his officer and/or director roles at the company. The Power of Attorney revokes previous authorizations and remains effective until Mr. Howard is no longer required to file under Section 16.